New Zealand Pharmac Funds Ambulance Medicines
Analysis based on 6 articles · First reported Jun 08, 2026 · Last updated Jun 09, 2026
The market for pharmaceutical suppliers in New Zealand could see increased demand or changes in procurement processes as Pharmac centralizes funding for ambulance medicines. This move is expected to create a more efficient and cost-effective healthcare system, potentially leading to better financial performance for companies that secure contracts with Pharmac.
The New Zealand Government has transferred the responsibility for funding ambulance medicines from New Zealand and ACC to Pharmac, effective July 1. This decision aims to create a more consistent and coordinated approach to emergency care across New Zealand, allowing ambulances and hospitals to access the same emergency medicines. Pharmac, known for its expertise in securing value for money, is expected to procure these medicines more cheaply. Following public consultation, Pharmac also added seven products to the funded list, including Glucose injection, Heparin, and Fentanyl pre-frilled syringes, to better reflect actual usage by ambulance services. Associate Health Minister David Seymour and Pharmac's acting Manager Claire Pouwels have both welcomed the change, emphasizing benefits for patient outcomes, supply, and taxpayer value.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard